NIPH Clinical Trials Search

JAPANESE
国立保健医療科学院
UMIN ID: UMIN000002149

Registered date:01/08/2009

A loading dose of teicoplanin in critically ill patients: effectiveness of dosing determined by data analysis software.

Basic Information

Recruitment status
Health condition(s) or Problem(s) studiedGram-positive infections
Date of first enrollment2007/10/01
Target sample size20
Countries of recruitmentJapan
Study typeInterventional
Intervention(s)initial loading dose of teicoplanin is determined by a data analysis software 400 mg of teicoplanin is administered for loading dose every 12 h three times and following 24 h.

Outcome(s)

Primary Outcometrough concentration of teicoplanin at 24, 48, 72hrs after first administration.
Secondary OutcomeThe duration of ICU stay and mortality rate

Key inclusion & exclusion criteria

Age minimum18years-old
Age maximumNot applicable
GenderMale and Female
Include criteriadiagnosed or suspected of Gram-positive infections in our intensive care unit
Exclude criteriahemodialysis therapy, infective endocarditis and purulent osteomyelitis.

Related Information

Contact

public contact
Name Hideaki Imanaka
Address 3-18-15 Kuramoto-cho, Tokushima, 770-8503 Japan Japan
Telephone 0886339347
E-mail imanakah@clin.med.tokushima-u.ac.jp
Affiliation Tokushima University Hospital Emergency and Critical Care Medicine
scientific contact
Name Masaji Nishimura
Address 3-18-15 Kuramoto-cho, Tokushima, 770-8503 Japan Japan
Telephone 0886339347
E-mail
Affiliation Tokushima University Hospital Emergency and Critical Care Medicine